普通外文研报
Tata Elxsi Ltd: Earnings downgrade cycle continues
研报英文原文证据摘录
Tata Elxsi Ltd: Earnings downgrade cycle continues
Idea
July 15, 2026 03:09 AM GMT
Morgan Stanley India Company Private Limited+MTata Elxsi Ltd | Asia Pacific Sulabh Govila, CFA
Equity Analyst
Earnings downgrade cycle Sulabh.Govila@morganstanley.comGaurav Rateria +91 22 6118-2249
Gaurav.Rateria@morganstanley.com +91 22 6118-2237
continues Shreshtha Chopra
Research Associate
What’s Changed Shreshtha.Chopra@morganstanley.com +91 22 6118-2227
Sakshi Rana
Tata Elxsi Ltd (TTEX.NS) From To Research Associate
Price Target Rs3,780.00 Rs3,400.00 Sakshi.Rana@morganstanley.com +91 22 6118-1002
Reaction to earnings
Strengthens our thesis Meaningful shortfall Meaningful revision lower
Impact to our thesis Financial results versus consensus Direction of next 12-month
consensus EPS
Source: Company data, Morgan Stanley Research Tata Elxsi Ltd (TTEX.NS, TELX IS)
India Technology | India
Key takeaways: a) negative surprise in margins, b) curtailment of Stock Rating Underweight
R&D spend in favor of AI spending. Industry View In-Line
Price target Rs3,400.00
Up/downside to price target (%) (8)
Key Takeaways Shr52-Weekprice,Rangeclose (Jul 14, 2026) Rs6,439.50-3,562.00Rs3,697.30
Sh out, dil, curr (mn) 62
1Q margins surprised negatively, driven by investments in the business. Mkt cap, curr (mn) Rs230,243
EV, curr (mn) Rs214,972
Management continues to aim for a high-single-digit revenue growth trajectory Avg daily trading value (mn) Rs1,444
for F27, even though it would require Healthcare to return to growth trends. Fiscal Year Ending 03/26 03/27e 03/28e 03/29e
EPS (Rs)** 112.15 116.52 130.90 144.94
Growth aspirations intact, but requires Healthcare to return to growth trends: Prior EPS (Rs)** - 127.64 140.77 154.19
EPS (Rs)§ 102.63 133.52 152.00 168.93
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器